.Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BA07_BenazeprilAndDiuretics.BenazeprilAndDiuretics .Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BA07_BenazeprilAndDiuretics.BenazeprilAndDiuretics| name: | BenazeprilAndDiuretics | |
| ATC code: | C09BA07 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 10 | mg |
| volume of distribution: | 96 | L |
| clearance: | 13 | L/h |
| other parameters in model implementation | ||
Benazepril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure and heart failure, often combined with thiazide diuretics such as hydrochlorothiazide for synergistic antihypertensive effects. This fixed-dose combination is approved and used in clinical practice for hypertension.
Estimated typical pharmacokinetic parameters for healthy adult subjects after oral administration of fixed-dose combination tablet (benazepril with hydrochlorothiazide).